Drugs for Alcoholic Liver Cirrhosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 72)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Losartan |
Approved |
Phase 4 |
|
114798-26-4 |
3961 |
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
[<sup>3</sup>H]-losartan
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
Cozaar
Cozaar®|DuP 753|MK-954
DuP 753
DUP 89
DuP-753
HGP1405
HGP-1405
|
Hyzaar
Lortaan
LOSARTAN
Losartan monopotassium salt
Losartan potassium
Losartic
MK-954
Monopotassium salt, losartan
Potassium, losartan
Salt, losartan monopotassium
|
|
2 |
|
Angiotensin II |
Approved, Investigational |
Phase 4 |
|
68521-88-0, 11128-99-7, 4474-91-3 |
172198 |
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
Angiotonin
|
Asp-arg-val-tyr-ile-his-pro-phe
Delivert
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-Α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
3 |
|
Spironolactone |
Approved |
Phase 4 |
|
1952-01-7, 52-01-7 |
5833 |
Synonyms:
ABBOLACTONE
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone a
Aldactone®|spiractin|spirotone
Alderon
Aldopur
Almatol
Alphapharm brand OF spironolactone
Alpharma brand OF spironolactone
Alter brand OF spironolactone
Altex
Aquareduct
Ashbourne brand OF spironolactone
Azupharma brand OF spironolactone
Betapharm brand OF spironolactone
Cardel brand OF spironolactone
CAROSPIR
CT Arzneimittel brand OF spironolactone
CT, Spiro von
CT-Arzneimittel brand OF spironolactone
Deverol
Dexo brand OF spironolactone
DIATENSEC
Dira
Duraspiron
Espironolactona
Espironolactona [INN-Spanish]
Espironolactona alter
Espironolactona mundogen
Euteberol
Flumach
Frumikal
Generosan brand OF spironolactone
GX SPIRONOL
Hormosan brand OF spironolactone
Jenapharm brand OF spironolactone
Jenaspiron
Lacalmin
Lacdene
LARACTONE
Mayoly-spindler brand OF spironolactone
Melarcon
Merck dura brand OF spironolactone
Mundogen brand OF spironolactone
Nefurofan
Novo spiroton
Novopharm brand OF spironolactone
Novo-spiroton
NovoSpiroton
NSC-150399
Osyrol
Pfizer brand OF spironolactone
|
Pharmafrid brand OF spironolactone
Practon
Roche brand OF spironolactone
Sagisal
SC-9420
Searle brand OF spironolactone
Sincomen
SNL
Spiractin
Spiresis
SPIRETIC
Spiridon
SPIRNOLACTONE
Spiro l.u.t.
Spiro von CT
Spirobeta
Spiroctan
SPIROCTAN 100
SPIROCTAN 25
SPIROCTAN 50
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono isis
Spironocompren
Spirono-isis
SPIRONOLACTONE
Spironolactone [BAN:INN:JAN]
Spironolactone A
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
SPIROSPARE 100
SPIROSPARE 25
Spiro-Tablinen
SPIROTONE
Sprioderm
Supra-puren
Suracton
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
Von CT, spiro
Wörwag brand OF spironolactone
Xenalon
|
|
4 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
318-98-9, 525-66-6 |
62882 4946 |
Synonyms:
(+-)-1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-NAPHTHYLOXY)-2-HYDROXY-3-ISOPROPYLAMINOPROPANE HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHOXY)-PROPAN-2-OL HYDROCHLORIDE
1-(ISOPROPYLAMINO)-3-(1-NAPHTHYLOXY)-2-PROPANOL HYDROCHLORIDE
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-ISOPROPYLAMINO-3-(1-NAPHTHOXY)-PROPAN-2-OL-HYDROCHLORIDE
Anaprilin
Anapriline
ANGILOL
APSOLOL
Avlocardyl
AY-64043
AY-64043-
BEDRANOL
BEDRANOL S.R.
Bedranol®|Hemangiol®|Inderal®|propranolol hydrochloride
Beprane
BERKOLOL
Betachron
Betadren
BETADUR CR
Betalong
Beta-Neg
BETA-PROGRANE MR
beta-Propranolol
Beta-Tablinen
Beta-Timelets
b-Propranolol
CARDINOL
Caridolol
Corpendol
Deralin
Dexpropranolol
Dl-Propranolol Hydrochloride
Dociton
DUPROMEX
Duranol
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HALF BETA-PROGRANE MR
HALF PROPANIX LA
HALF PROPATARD LA
HALF-BEPRANE CR
HALF-BETADUR CR
HALF-INDERAL LA
HEMANGEOL
Hydrochloride, propranolol
ICI-45520
Inderal
INDERAL LA
|
Inderide
INDERIDE-40/25
INDERIDE-80/25
Indobloc
INNOPRAN
INNOPRAN XL
Intermigran
Kemi S
LEDERPRONOL
LOPRANOL LA
Migrastat
NSC-91523
Obsidan
Obzidan
Oposim
Prano-Puren
PROBETA LA
Propanalol
Propanix
PROPANIX LA
PROPANIX-10
PROPANIX-160
PROPANIX-160 SR
PROPANIX-40
PROPANIX-80
Propanolol
PROPATARD LA
Prophylux
Propranalol
PROPRANOLOL
PROPRANOLOL HCL
Propranolol Hcl Intensol
Propranolol hydrochloride
PROPRANOLOL HYDROCHLORIDE INTENSOL
Propranololo
Propranololum
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
RAPRANOL SR
Rapynogen
Reducor
Reducor Line
Rexigen
SAGITTOL
Servanolol
SLO-BLOK
SLO-PRO
SLOPROLOL
Sumial
SYPROL
TESNOL
Î’-propranolol
|
|
5 |
|
Angiotensinogen |
|
Phase 4 |
|
|
16133225 |
Synonyms:
Hypertensinogen
Proangiotensin
Renin substrate
Renin substrate tetradecapeptide
|
Renin-substrate
Serpin a8
SERPINA8
Tetradecapeptide, renin substrate
|
|
6 |
|
Angiotensin Receptor Antagonists |
|
Phase 4 |
|
|
|
7 |
|
Angiotensin II Type 1 Receptor Blockers |
|
Phase 4 |
|
|
|
8 |
|
Giapreza |
|
Phase 4 |
|
|
|
9 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
10 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
11 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
12 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
13 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
14 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
15 |
|
Hormones |
|
Phase 4 |
|
|
|
16 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
17 |
|
Hormone Antagonists |
|
Phase 4 |
|
|
|
18 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
19 |
|
diuretics |
|
Phase 4 |
|
|
|
20 |
|
Mineralocorticoids |
|
Phase 4 |
|
|
|
21 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 4 |
|
|
|
22 |
|
Iron |
Approved |
Phase 3 |
|
7439-89-6 |
29936 |
Synonyms:
Carbonyl iron
Eisen
Electrolytic iron
Fe
FE (III) ion
Fe(3+)
Fe(III)
fer
Ferric ion
Ferric iron
Ferrum
|
Ferrum metallicum
Hierro
Iron powder
Iron(3+)
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (fe(3+))
Iron, reduced
Reduced iron
|
|
23 |
|
Benzocaine |
Approved, Investigational |
Phase 3 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
24 |
|
Tannic acid |
Approved |
Phase 3 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
25 |
|
Caffeine |
Approved |
Phase 2 |
|
58-08-2 |
2519 |
Synonyms:
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE
1,3,7-Trimethyl-2,6-dioxopurine
1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione
1,3,7-Trimethylpurine-2,6-dione
1,3,7-TRIMETHYLPURINE-2,6-QUINONE
1,3,7-Trimethylxanthine
137X
1-Methyltheobromine
1-Methyl-theobromine
3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion
3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
7-Methyl theophylline
7-Methyltheophylline
Alert-Pep
Anhydrous caffeine
Anhydrous caffeine (JP15)
Anoquan
Berlin-chemie brand OF caffeine
Bristol-myers squibb brand OF caffeine
Cafamil
CAFCIT
Cafecon
Cafeina
Cafeína
Cafeine
Caféine
Cafergot
Caffedrine
Caffedrine Caplets
Caffein
Caffeine
CAFFEINE MELTING POINT STANDARD
Caffeine Pure
Caffeine, Anhydrous
Caffeine, Monohydrate
Caffeine, Synthetic
Caffeinum
Caffine
Cafipel
CFF
Coffein
COFFEINE
Coffeinum
Coffeinum N
Coffeinum purrum
Compound 65
Darvon Compound
Darvon Compound-65
Dasin
Dexitac
Dexitac Stay Alert Stimulant
Dhc Plus
Diurex
Durvitan
Eldiatric C
Enerjets
Ercatab
Esgic
Esgic-Plus
FEMA NO. 2224
Femcet
Fioricet
Fiorinal
GlaxoSmithKline brand OF caffeine
Guaranine
Hycomine
Invagesic
|
Invagesic Forte
Keep Alert
Kofein
Koffein
Lanorinal
Mateina
Mateína
Maximum Strength Snapback Stimulant Powders
Medigesic Plus
Merck dura brand OF caffeine
Methyltheobromide
Methyltheobromine
Methylxanthine theophylline
Migergot
Miudol
Monohydrate caffeine
Monomethyl Derivative of Theophylline
Natural Caffeinum
Nix Nap
No doz
Nodaca
No-Doz
NODOZ
NODOZ CAPLETS AND CHEWABLE TABLETS
Nodoz Maximum Strength Caplets
Norgesic
Norgesic Forte
NSC-5036
Organex
Orphengesic
Orphengesic Forte
Passauer brand OF caffeine
Pep-Back
Percoffedrinol N
Percutaféine
Peyona®
Phensal
Pierre fabre brand OF caffeine
PRO-PLUS
Propoxyphene
Propoxyphene Compound 65
Propoxyphene Compound-65
Quick pep
Quick-pep
QuickPep
Refresh'n
Republic drug brand OF caffeine
Respia
Seid brand OF caffeine
SK 65 Compound
Stim
Synalgos-Dc
Teina
Teína
Thein
Theine
Theobromine ME
Theophylline ME
Thompson brand 1 OF caffeine
Thompson brand 2 OF caffeine
Triad
Ultra Pep-Back
Vivarin
Wake-Up
Wigraine
YEAST-VITE
ZANTHINE
|
|
26 |
|
Baclofen |
Approved |
Phase 1, Phase 2 |
|
1134-47-0 |
2284 |
Synonyms:
(+-)-Baclofen
4-Amino-3-(4-chlorophenyl)butyrate
4-Amino-3-(4-chlorophenyl)butyric acid
Alphapharm brand OF baclofen
apo Baclofen
apo-Baclofen
ApoBaclofen
Apotex brand OF baclofen
Ashbourne brand OF baclofen
ASTA medica brand OF baclofen
Athena brand OF baclofen
Atrofen
AWD, baclofen
b-(4-Chlorophenyl)gaba
b-(Aminomethyl)-4-chlorobenzenepropanoate
b-(Aminomethyl)-4-chlorobenzenepropanoic acid
b-(Aminomethyl)-p-chlorohydrocinnamate
b-(Aminomethyl)-p-chlorohydrocinnamic acid
b-(p-Chlorophenyl)-g-aminobutyrate
b-(p-Chlorophenyl)-g-aminobutyric acid
BA-34647
BACLOFEN
Baclofen alphapharm brand
Baclofen apotex brand
Baclofen ashbourne brand
Baclofen athena brand
Baclofen awd
Baclofen ciba-geigy brand
Baclofen irex brand
Baclofen isis brand
Baclofen medtronic brand
Baclofen novartis brand
Baclofen nu-pharm brand
Baclofen pharmascience brand
Baclofene
Baclofène
Baclofène irex
Baclofène-irex
BaclofèneIrex
Baclofeno
Baclofenum
Baclon®|Kemstro®|Lioresal®
Baclophen
Baclospas
BACLOSPAS-10
beta-(4-Chlorophenyl)gaba
beta-(Aminomethyl)-4-chlorobenzenepropanoate
beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
beta-(Aminomethyl)-p-chlorohydrocinnamate
beta-(Aminomethyl)-p-chlorohydrocinnamic acid
|
beta-(p-Chlorophenyl)-gamma-aminobutyrate
beta-(p-Chlorophenyl)-gamma-aminobutyric acid
Chlorophenyl gaba
Ciba geigy brand OF baclofen
CIBA34,647ba
CIBA-34,647-ba
Ciba-geigy brand OF baclofen
Clofen
DL-4-Amino-3-p-chlorophenylbutanoate
DL-4-Amino-3-p-chlorophenylbutanoic acid
DL-Baclofen
GABA, chlorophenyl
GABLOFEN
g-Amino-b-(p-chlorophenyl)butyrate
g-Amino-b-(p-chlorophenyl)butyric acid
gamma-Amino-beta-(p-chlorophenyl)butyrate
gamma-Amino-beta-(p-chlorophenyl)butyric acid
Gen baclofen
Gen-baclofen
GenBaclofen
Genpharm
Irex brand OF baclofen
Isis brand OF baclofen
Kemstro
Lebic
Lioresal
LIORESAL INTRATH
LYFLEX
Medtronic brand OF baclofen
Novartis brand OF baclofen
Nu baclo
Nu pharm brand OF baclofen
Nu-baclo
NuBaclo
Nu-pharm brand OF baclofen
PCP-GABA
Pharmascience brand OF baclofen
PMS Baclofen
PMSBaclofen
PMS-Baclofen
Î’-(4-chlorophenyl)gaba
Î’-(aminomethyl)-4-chlorobenzenepropanoate
Î’-(aminomethyl)-4-chlorobenzenepropanoic acid
Î’-(aminomethyl)-p-chlorohydrocinnamate
Î’-(aminomethyl)-p-chlorohydrocinnamic acid
Β-(p-chlorophenyl)-γ-aminobutyrate
Β-(p-chlorophenyl)-γ-aminobutyric acid
Γ-amino-β-(p-chlorophenyl)butyrate
Γ-amino-β-(p-chlorophenyl)butyric acid
|
|
27 |
|
GABA Agonists |
|
Phase 1, Phase 2 |
|
|
|
28 |
|
Ritonavir |
Approved, Investigational |
Phase 1 |
|
155213-67-5 |
392622 |
Synonyms:
538, ABT
A-84538
A-84538|ABBOTT-84538|ABT 538|ABT-538|Norvir®|RTV
Abbott 84538
ABBOTT-84538
ABT 538
ABT-538
|
N-[(1S,3S,4S)-1-BENZYL-3-HYDROXY-5-PHENYL-4-{[(1,3-THIAZOL-5-YLMETHOXY)CARBONYL]AMINO}PENTYL]-N~2~-(METHYL{[2-(1-METHYLETHYL)-1,3-THIAZOL-4-YL]METHYL}CARBAMOYL)-L-VALINAMIDE
Norvir
Norvir Sec
NSC-693184
Ritonavir
RITONAVIR RELATED COMPOUNDS MIXTURE
Ritonavirum
|
|
29 |
|
Peginterferon alfa-2a |
Approved, Investigational |
Phase 1 |
|
198153-51-4 |
|
Synonyms:
PEGASYS
PEG-IFN alfa-2A
PEG-Interferon alfa-2A
PEGINTERFERON ALFA-2A
PEGYLATED IFN-ALPHA-2A
Pegylated Interfeaon alfa-2A
|
Pegylated interferon alfa-2a
Pegylated interferon alpha-2a
Pegylated-interferon alfa 2a
RO-258310000
ROFERON-A
|
|
30 |
|
Ribavirin |
Approved |
Phase 1 |
|
36791-04-5 |
37542 |
Synonyms:
1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-b-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide
1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
1-Î’-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
1-Î’-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
Copegus
Copegus®|RBV|Rebetol®|ribofluranosyl carboxamide|Virazole®
Dermatech brand OF ribavirin
Essex brand OF ribavirin
Grossman brand OF ribavirin
ICN brand OF ribavirin
Merck brand OF ribavirin
NSC-163039
Pfizer brand OF ribavirin
RBV
Rebetol
Rebetron
Rebretron
Ribamide
Ribamidil
Ribamidyl
RIBAPAK
Ribasphere
RIBAV
RIBAVARIN
Ribavirin
|
Ribavirin Capsules
Ribavirin merck brand
Ribavirin Triphosphate
Ribavirina
Ribavirina [INN-Spanish]
Ribavirine
Ribavirine [INN-French]
Ribavirin-TP
Ribavirinum
Ribavirinum [INN-Latin]
RIBOFLURANOSYL CARBOXAMIDE
Ribovirin
RTC
RTCA
RTP
SCH 18908
SCH-18908
Three rivers pharmaceuticals brand OF ribavirin
Tribavirin
Varazid
Vilona
VIRAMID
Viramide
VIRAZID
Virazide
Virazole
Virazole 5'-triphosphate
|
|
31 |
|
Tipranavir |
Approved, Investigational |
Phase 1 |
|
174484-41-4 |
65027 54682461 |
Synonyms:
3'-((1R)-1-((6R)-5,6-DIHYDRO-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-2H-PYRAN-3-YL)PROPYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONANILIDE
APTIVUS
N-{3-[(1R)-1-[(2R)-6-hydroxy-4-oxo-2-(2-phenylethyl)-2-propyl-3,4-dihydro-2H-pyran-5-yl]propyl]phenyl}-5-(trifluoromethyl)pyridine-2-sulphonamide
|
|
|
32 |
|
Interferon alpha-2 |
|
Phase 1 |
|
|
|
33 |
|
Antiviral Agents |
|
Phase 1 |
|
|
|
34 |
|
Anti-Retroviral Agents |
|
Phase 1 |
|
|
|
35 |
|
Anti-Infective Agents |
|
Phase 1 |
|
|
|
36 |
|
Iron-Dextran Complex |
|
Phase 1 |
|
|
|
37 |
|
Antimetabolites |
|
Phase 1 |
|
|
|
38 |
|
interferons |
|
Phase 1 |
|
|
|
39 |
|
Anti-HIV Agents |
|
Phase 1 |
|
|
|
40 |
|
Interferon-alpha |
|
Phase 1 |
|
|
|
41 |
|
HIV Protease Inhibitors |
|
Phase 1 |
|
|
|
42 |
|
Cytochrome P-450 Enzyme Inhibitors |
|
Phase 1 |
|
|
|
43 |
|
Cytochrome P-450 CYP3A Inhibitors |
|
Phase 1 |
|
|
|
44 |
|
protease inhibitors |
|
Phase 1 |
|
|
|
Synonyms:
|
45 |
|
Zinc cation |
Approved, Experimental, Investigational |
|
|
7440-66-6, 23713-49-7 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
Mannosidase b, alpha
Neutral alpha mannosidase
|
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc ion(2+)
Zinc(2+)
Zinc(II)
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
zinc|zinc ion
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
46 |
|
Zinc sulfate |
Approved, Investigational |
|
|
7733-02-0 |
|
Synonyms:
Zinc sulfate (anhydrous)
Zinc sulfate anhydrous
Zinc sulfate, anhydrous
|
Zinc sulphate
Zinc sulphate anhydrous
Zinc sulphate, anhydrous
|
|
47 |
|
Lactulose |
Approved |
|
|
4618-18-2 |
11333 |
Synonyms:
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5R)-4,5-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)TETRAHYDROFURAN-3-YL]OXY-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-DIMETHYLOL-TETRAHYDROFURAN-3-YL]OXY-6-METHYLOL-TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-[[(2R,3S,4S,5S)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)-3-TETRAHYDROFURANYL]OXY]-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
(2S,3R,4S,5R,6R)-2-{[(2R,3S,4S,5R)-4,5-DIHYDROXY-2,5-BIS(HYDROXYMETHYL)OXOLAN-3-YL]OXY}-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
4-O-b-D-Galactopyranosyl-D-fructofuranose
4-O-b-D-Galactopyranosyl-D-fructose
4-O-beta-delta-Galactopyranosyl-delta-fructofuranose
4-O-beta-delta-Galactopyranosyl-delta-fructose
4-O-beta-D-Galactopyranosyl-D-fructofuranose
4-O-beta-D-Galactopyranosyl-D-fructose
4-O-Î’-D-galactopyranosyl-D-fructofuranose
4-O-Î’-D-galactopyranosyl-D-fructose
ACILAC
Amivalex
Bifiteral
Cephulac
CEPHULAC SYRUP
CHOLAC
Chronulac
CONSTILAC
|
CONSTULOSE
delta-Lactulose
D-Lactulose
Duphalac
DUPHALAC DRY
E966
ENULOSE
EVALOSE
GENERLAC
HEPTALAC
Lactulosa
Lactulose
LACTULOSE JP17
Lactulosum
LAXILOSE
LAXOSE ORANGE
LEMLAX
Normase
OSMOLAX
PORTALAC
REGULOSE
|
|
48 |
|
Furosemide |
Approved, Vet_approved |
|
|
54-31-9 |
3440 |
Synonyms:
2-Furfurylamino-4-chloro-5-sulfamoylbenzoate
2-Furfurylamino-4-chloro-5-sulfamoylbenzoic acid
2-Furfurylamino-4-chloro-5-sulphamoylbenzoate
2-Furfurylamino-4-chloro-5-sulphamoylbenzoic acid
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulfamoyl-N-furfuryl-anthranilic acid
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilate
4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilate
4-Chloro-N-(2-furylmethyl)-5-sulphamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulfamoylanthranilate
4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid
4-Chloro-N-furfuryl-5-sulphamoylanthranilate
4-Chloro-N-furfuryl-5-sulphamoylanthranilic acid
Acetic acid potassium salt
Aisemide
Aldalix
Aldic
Aluzine
ALUZINE 20
ALUZINE 40
ALUZINE 500
Anfuramaide
Apo-frusemide
Apo-furosemide
AQUAMED
Aquarid
Aquasin
Arasemide
Beronald
Bioretic
Bristab
Bristurin
Cetasix
Depix
Desal
Desdemin
Di-Ademil
DIHYDROFLUMETHIAZIDE
dihydroflumethiazide|frusemide|Lasix®|methforylthiazidine
Dirine
Disal
Discoid
Disemide
Diucardin
Diumide-K
Diural
Diurapid
DIURESAL
Diuretic salt
Diurin
Diurolasa
Diusemide
Diusil
Diuzol
Dranex
Dryptal
Durafurid
Edemid
Edenol
Eliur
Elodrine
Endural
Errolon
Eutensin
Farsix
Finuret
Fluidrol
Fluss
Franyl
FROOP
FRUMAX
Frumex
Frumide
Frumil
Frusedan
Frusema
Frusemid
Frusemide
Frusemin
Frusenex
Frusetic
Frusid
FRUSOL
Fulsix
Fuluvamide
Fuluvamine
Furanthril
Furanthryl
Furantral
Furantril
Furanturil
Furesis
Furetic
Furex
Furfan
Furix
Furmid
Furo-basan
Furobeta
Furocot
Furodiurol
Furodrix
Furomen
Furomex
Furomide m.d.
Furo-puren
Furorese
Furosan
Furose
Furosedon
Furosemid
Furosemida
Furosemida [INN-Spanish]
Furosemide
|
Furosemide "mita"
Furosemide monohydrochloride
Furosemide monosodium salt
Furosemidu
Furosemidu [Polish]
Furosemidum
Furosemidum [INN-Latin]
Furosemix
Furoside
Furosifar
Furosix
Furoter
Furovite
Fursemid
Fursemida
Fursemide
Fursol
Fusid
Fusidic acid
Golan
Hissuflux
Hydol
Hydrenox
Hydrex
Hydro
Hydroled
Hydro-rapid
Impugan
Jenafusid
Katlex
Kofuzon
Kolkin
Kutrix
Lasemid
Lasex
Lasiletten
Lasilix
Lasix
LASIX (TN)
LASIX RET
Lasix retard
Lasix Special
Laxur
Lazix
LB-502
Leodrine
Less diur
Liside
Logirene
Lowpston
Lowpstron
Luscek
Macasirool
Marsemide
Metflorylthiazidine
METHFORYLTHIAZIDINE
Mirfat
Mita
Moilarorin
Myrosemide
Nadis
Nelsix
Neo-renal
Nephron
Nicorol
Novosemide
NSC-269420
Octan draselny
Odemase
Odemex
Oedemex
Olmagran
Osyrol
Polysquall a
Prefemin
Profemin
Promedes
Promide
Protargen
Puresis
Radisemide
Radonna
Radouna
Retep
Rodiuran
Rontyl
Rosemide
Rosis
Rusyde
Sal diureticum
Salinex
Salix
Salix (brand OF furosemide)
Salurex
Salurid
Saluron
Seguril
Selectofur
Sigasalur
Sisuril
Spirofur
Synephron
TENKOFRUSE
Transit
Trofurit
Uremide
Uresix
Urex
Urex-m
Urian
Uridon
Uritol
Urosemide
Vergonil
Vesix
Yidoli
Zafimida
|
|
49 |
|
Norfloxacin |
Approved |
|
|
70458-96-7 |
4539 |
Synonyms:
1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsaeure
1-Ethyl-6-fluor-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-chinolincarbonsäure
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
BACCIDAL
CHIBROXIN
Merck brand OF norfloxacin
MK-366
|
NFLX
NORFLOXACIN
Norfloxacin merck brand
Norfloxacine
Norfloxacino
Norfloxacinum
Noroxin
QUINABIC
UTINOR
|
|
50 |
|
Ciprofloxacin |
Approved, Investigational |
Early Phase 1 |
|
85721-33-1, 93107-08-5 |
2764 |
Synonyms:
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylate
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-CYCLOPROPYL-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylIC ACID
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylate
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylate
1-Cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Anhydrous, ciprofloxacin hydrochloride
Bacquinor
BAY O 9867 FREE BASE
Baycip
BAY-O-9867 FREE BASE
BAYQ3939
BAY-Q-3939
Bernoflox
CETRAXAL
Ciflox
Cifloxin
CILOXAN
Ciprinol
Cipro
Cipro I.V.
Cipro XL
Cipro XR
CIPROBAY
|
Ciprocinol
Ciprodar
Ciprofloxacin
Ciprofloxacin dihydrochloride
Ciprofloxacin HCl
Ciprofloxacin hydrochloride
Ciprofloxacin hydrochloride anhydrous
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride monohydrate
Ciprofloxacina
Ciprofloxacine
Ciprofloxacino
Ciprofloxacinum
Cipromycin
Ciproquinol
Ciproxan
Ciproxin
CPFX
CPR867
Flociprin
Floxin
Hydrochloride anhydrous, ciprofloxacin
Hydrochloride, ciprofloxacin
Monohydrate, ciprofloxacin monohydrochloride
Monohydrochloride monohydrate, ciprofloxacin
Ocuflox
OTIPRIO
Proquin XR
Septicide
VELMONIT
Velomonit
|
|
Interventional clinical trials:
(show all 32)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Losartan in the Prevention of Sodium Retention and Ascites in Liver Cirrhosis - a Prospective Randomized Long-Term Study |
Unknown status |
NCT00239096 |
Phase 4 |
losartan (drug) |
2 |
Hemodynamic Effects of Chronic Administration of Spironolactone, Propranolol and Their Association in Alcoholic Cirrhotic Patients |
Terminated |
NCT00188045 |
Phase 4 |
Propranolol - Spironolactone |
3 |
A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis |
Recruiting |
NCT04689152 |
Phase 3 |
|
4 |
Influence of Iron Depletion by Phlebotomy on the Risk of Hepatocellular Carcinoma Occurrence in Patients With Compensated Alcoholic Cirrhosis. Prospective, Multicentre, Randomized Trial |
Terminated |
NCT01342705 |
Phase 3 |
|
5 |
The Evaluation of Effectiveness and Safety for New Therapy With Bone Marrow Derived Autologous Mesenchymal Stem Cell for Hepatic Failure Caused by Alcoholic Liver Cirrhosis |
Unknown status |
NCT01741090 |
Phase 2 |
|
6 |
Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient. |
Completed |
NCT01875081 |
Phase 2 |
|
7 |
A Parallel Group Randomized Open Blinded End Point Evaluation, Multicentric, Dose Escalation, Phase -II Study Assessing the Safety and Efficacy of Intraarterial (Hepatic) Ex-vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Alcoholic Liver Cirrhosis |
Completed |
NCT01591200 |
Phase 2 |
|
8 |
Maintaining Alcohol Abstinence in Alcoholic Patients With Liver Cirrhosis: Efficacy and Safety of Baclofen Administration in a Randomized Double Blind Controlled Study |
Completed |
NCT00525252 |
Phase 1, Phase 2 |
Baclofen;placebo |
9 |
A Phase I, Open-Label, Single-Dose Study to Evaluate the Safety and Efficacy of Hepatic Artery Injection of Autologous Human Bone Marrow-Derived Mesenchymal Stem Cells (Cellgramâ„¢) in Patients With Alcoholic Liver Cirrhosis |
Unknown status |
NCT03838250 |
Phase 1 |
|
10 |
Open Label, Study to Determine the Pharmacokinetic Interactions of Steady State Tipranavir/Ritonavir (500/200 mg) and Steady State Ribavirin and Pegylated Interferon Alfa 2a in HIV Negative, HCV Infected Subjects With Mild Hepatic Impairment and the Pharmacokinetic Properties of Tipranavir/Ritonavir in HIV Negative, HCV, HBV, Hepatitis Delta Infected Subjects or Alcoholic Cirrhosis Subjects With Moderate Hepatic Impairment |
Completed |
NCT02259855 |
Phase 1 |
Tipranavir;Ritonavir;Pegylated interferon;Ribavirin |
11 |
A Pilot Clinical Study to Evaluate Safety, Tolerability and Preliminary Efficacy of Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cell in the Treatment of Decompensated Alcoholic Cirrhosis |
Recruiting |
NCT05155657 |
Phase 1 |
|
12 |
Prognostic Value of Liver Volume on Acute Decompensation of Alcoholic Cirrhosis, a Prospective Multicenter Observational Study |
Unknown status |
NCT03508388 |
|
|
13 |
CIRRAL: Hepatocellular Carcinoma in Patients With Uncomplicated Alcoholic Cirrhosis: Incidence and Predictive Factors. A Multicentric Prospective Cohort |
Unknown status |
NCT01213927 |
|
|
14 |
Phenotypical and Pathophysiological Characterization of Patients With Alcohol-related Liver Disease |
Unknown status |
NCT04363424 |
|
|
15 |
Long-term Follow-up Study of Livercellgram in Alcoholic Liver Cirrhosis Patients Who Completed Livercellgram Phase 2 Study |
Completed |
NCT02806011 |
|
|
16 |
A Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Daily Oral Zinc Sulfate (220 mg) in Subjects With Alcoholic Cirrhosis |
Completed |
NCT02072746 |
|
|
17 |
Randomized Trial Comparing Liver Transplantation to Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis |
Completed |
NCT00701792 |
|
|
18 |
Genetical Predisposition in Hepatocellular Carcinoma : Pangenomic Link Study During Alcoholic Cirrhosis |
Completed |
NCT01065233 |
|
|
19 |
Adipose Tissue Involvement in Alcohol-induced Liver Inflammation in Human : Study of Pro- and Anti-inflammatory Cytokines and ADIPOKINES.. |
Completed |
NCT00388323 |
|
|
20 |
Makuuchi Versus Barcelona Clinic of Liver Cancer Criteria in Cirrhotic Patients With Hepatocellular Carcinoma. Does Etiology of Cirrhosis Influence the Relationship Between the Portal Pressure and Quantitative Tests of Liver Function? |
Completed |
NCT00827723 |
|
|
21 |
Randomised Open-label Multicenter Study Evaluating Ciprofloxacin in Severe Alcoholic Hepatitis in Addition to Prednisolon Therapy |
Completed |
NCT02326103 |
Early Phase 1 |
Ciprofloxacin;Placebo |
22 |
Validation of an Accelerated Procedure of Selection in Early Liver Transplantation for Severe Alcoholic Hepatitis Not Responding to Medical Treatment QuickTransHAA. |
Completed |
NCT01756794 |
|
|
23 |
A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area |
Completed |
NCT00913757 |
|
|
24 |
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study |
Recruiting |
NCT05093881 |
|
|
25 |
A Multi-center, Randomized, Placebo-controlled Trial of S-Adenosylmethionine (SAMe) in Patients With Alcoholic Cirrhosis |
Recruiting |
NCT04250259 |
|
|
26 |
EUS Based Prevalence of Chronic Pancreatitis in Alcoholic Cirrhosis: Any Difference Between Alcoholic and Non-alcoholic Patients |
Recruiting |
NCT04245189 |
|
|
27 |
Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease |
Recruiting |
NCT04106518 |
|
|
28 |
Mild Hypothermia and Acute Kidney Injury in Liver Transplantation (MHALT) Trial |
Recruiting |
NCT03534141 |
|
|
29 |
Copenhagen Liver Cohort Study: Disease Characteristics, Outcomes and Rehabilitation in Liver Cirrhosis - A Prospective Cohort Study |
Recruiting |
NCT04422223 |
|
|
30 |
Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota - a Randomized Controlled Clinical Trial |
Active, not recruiting |
NCT03863730 |
|
|
31 |
Early Detection of Advanced Liver Fibrosis in Patients With Excessive Alcohol Intake |
Not yet recruiting |
NCT04070508 |
|
|
32 |
A Randomized, Pragmatic, Outcome-assessor-blinded Study of an SMS-message-based Lifestyle Intervention in Patients With Decompensated Liver Cirrhosis |
Terminated |
NCT02811887 |
|
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Alcoholic Liver Cirrhosis:
Embryonic/Adult Cultured Cells Related to Alcoholic Liver Cirrhosis:
|